GlassScriptPhysician profile
Brittany Foreman
NPI 1174908164
$5,175.77
in general payments reported to CMS, 2019-2025
42 companies · $1,447 in 2025
The $1,447 reported for 2025 was more than what 92% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $962 · 2022: $974 · 2023: $740 · 2024: $1,052 · 2025: $1,447.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,155 · Education: $84.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,154.77 |
| Education | $84.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,223.01 | 2021-2025 | |
| Lilly USA, LLC | $568.99 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Astrazeneca Pharmaceuticals LP | $446.52 | 2022-2025 | Breztri, Airsupra, Farxiga |
| Novo Nordisk INC | $413.76 | 2021-2025 | Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $221.72 | 2022-2025 | Jardiance |
| Amgen INC. | $199.84 | 2021-2025 | Repatha, Otezla, Repatha |
| Vanda Pharmaceuticals INC. | $185.54 | 2024-2025 | Fanapt, Hetlioz |
| Astellas Pharma US INC | $125.33 | 2021-2025 | Veozah |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $122.14 | 2025 | Caplyta |
| Pfizer INC. | $119.17 | 2022-2025 | |
| Axsome Therapeutics, INC. | $115.20 | 2024-2025 | Auvelity |
| Xeris Pharmaceuticals, INC. | $102.23 | 2022-2024 | Gvoke Hypopen |
| Amarin Pharma, INC. | $93.59 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $85.08 | 2022 | |
| Exact Sciences Corporation | $84.91 | 2023-2025 | Cologuard Collection Kit |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany Foreman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.